Confusion in Pentamidine Dosage Guidelines
Author Information
Author(s): Dorlo Thomas P. C., Kager Piet A.
Primary Institution: Center for Infection and Immunity Amsterdam (CINIMA), Division of Infectious Diseases, Tropical Medicine and AIDS, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands
Hypothesis
The confusion in pentamidine dosage guidelines may lead to subtherapeutic treatment in human African trypanosomiasis and leishmaniasis.
Conclusion
There is a need for clearer guidelines on pentamidine dosage to avoid confusion and ensure effective treatment.
Supporting Evidence
- Pentamidine has been used for decades to treat human African trypanosomiasis and leishmaniasis.
- Confusion in dosage arises from different labeling of pentamidine formulations based on salt or base.
- Only pentamidine isethionate is currently available, but guidelines still reference the base form.
- Historical guidelines have led to inconsistent dosing recommendations.
Takeaway
Doctors need to be careful about how much pentamidine they give to patients because the way it's labeled can be confusing, and giving the wrong amount might not help the patients get better.
Methodology
The article reviews historical guidelines and clinical reports regarding pentamidine dosage for treating HAT and leishmaniasis.
Potential Biases
Potential bias in interpreting historical data and guidelines may affect the conclusions drawn.
Limitations
The study does not provide new clinical trial data but reviews existing guidelines and literature.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website